Hjem › Kolorektal kreft › Utah › Salt Lake City
Kliniske studier for Kolorektal kreft i Salt Lake City, UT
22 studier for Kolorektal kreft søker deltakere på steder i og rundt Salt Lake City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
RekruttererFase 1
- Huntsman Cancer Institute, Salt Lake City
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Rekrutterer
- University of Utah, Salt Lake City
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
RekruttererFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
RekruttererFase 2/3
- Local Institution - 0426, Salt Lake City
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekruttererFase 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
RekruttererFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
RekruttererFase 3
- Clinical Study Site, Salt Lake City
- Clinical Study Site, Salt Lake City
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
RekruttererFase 1
- Huntsman Cancer Institute, Salt Lake City
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekruttererFase 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Utah Cancer Specialists, Salt Lake City
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Utah Cancer Specialists, Salt Lake City
- University of Utah Health Huntsman Cancer Hospital, Salt Lake City
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RekruttererFase 1
- START Mountain Region, Salt Lake City
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RekruttererFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RekruttererFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
RekruttererFase 1
- Huntsman Cancer Institute, Salt Lake City
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
RekruttererFase 2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekruttererFase 1/2
- Huntsman Cancer Institute, Salt Lake City
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekruttererFase 1/2
- Huntsman Cancer Institute, Salt Lake City
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekruttererFase 1/2
- START Center for Cancer Care - Mountain Region, Salt Lake City
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
RekruttererFase 1/2
- Huntsman Cancer Institute, Salt Lake City
ColoCare Study - Colorectal Cancer Cohort
RekruttererObservasjonsstudie
- Huntsman Cancer Institute, Salt Lake City
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
RekruttererObservasjonsstudie
- Utah Cancer Specialists, Salt Lake City
Kolorektal kreft-studier i andre byer
- Houston, TX102 studier
- New York City, NY78 studier
- Nashville, TN69 studier
- Boston, MA63 studier
- Los Angeles, CA59 studier
- Arlington, VA52 studier
- St. Louis, MO50 studier
- San Antonio, TX46 studier
- Philadelphia, PA44 studier
- Grand Rapids, MI40 studier
- Baldwin Park, CA37 studier
- Chicago, IL34 studier
Andre studier i Salt Lake City
- Ikke-småcellet lungekreft31 studier
- Kreft (alle typer)27 studier
- Brystkreft27 studier
- Lungekreft21 studier
- Melanom21 studier
- Multipelt myelom21 studier
- Metastatisk kreft20 studier
- Eggstokkreft19 studier
- Fedme18 studier
- Akut myelogen leukemi17 studier
- Hjertesvikt17 studier
- Prostatakreft15 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.